OTC Watch

All stocks / KBLB

Kraig Biocraft Laboratories, Inc. KBLB

Kraig Biocraft Laboratories (KBLB): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated float OTCQBMichigan, USA
Live quote on OTC Markets

Market listing

Full name
KRAIG BIOCRAFT LABORATORIES INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 16
Website
www.KraigLabs.com
Source: Stockwatch, 2026-11-17

News headlines

From National Geographic to Forbes: Kraig Biocraft Builds Visibility as Spider Silk Commercialization Advances
2026-11-17 09:15 · News Release
Kraig Biocraft Laboratories CEO Publishes Forbes Technology Council Article on the Future of Bio-Engineered Materials
2026-11-17 07:05 · News Release
Kraig Labs Advances Commercial Spider Silk Production with New Customer Shipments and New Silkworm Research
2026-11-10 09:15 · News Release
Kraig Labs Ships Spider Silk to Developers Across Global Industries
2026-11-09 09:56 · News Release
Kraig Labs Advances Commercial Spider Silk Production with New Customer Shipments and New Silkworm Research
2026-11-05 10:31 · News Release
Kraig Biocraft Laboratories Takes Spider Silk Optimization Beyond Genetics with New Dietary Additive Program
2026-11-02 07:05 · News Release
Why Kraig Labs' Spider Silk Could Have a Future in Aerospace
2026-10-30 09:15 · News Release
Kraig Labs Moves Beyond Bold Breakthrough
2026-10-26 09:39 · News Release
Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator
2026-10-26 07:05 · News Release
Kraig Biocraft Laboratories Selected to Present to the International Sericultural Commission Congress on the Impact of Bioengineering on Commercial Silk Markets
2026-10-19 07:05 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Net loss
($3,623,353)
What it means

It spends more than it earns

Under strain

The company lost $3.6 million in the year. It reported no sales.

The report says
Cash and cash equivalents
$1,790,236
Net cash used in operating activities
($1,788,970)
What it means

It has cash for a while

Steady

It had $1.8 million in the bank and used about $149,081 a month. At that pace the money lasts about 12 months unless it borrows or sells more shares.

The report says
Total assets
$2,565,540
Total liabilities
$10,564,498
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $2.6 million. Its debts and unpaid bills add up to $10.6 million. That is about $4.12 owed for every $1 owned.

What this adds up to

2 of 3 checks show strain. It spends more than it earns. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-03-30

Estimated float about 1,099,791,733 shares as of 2026-03-30: 1,099,791,733 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2022-05-06
957.5M
2022-08-01
978.8M
2022-11-14
1.03B
2023-03-29
1.03B
2023-05-12
1.03B
2024-04-01
1.04B
2025-03-28
1.04B
2026-03-30
1.10B

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 10-Q10-Q
2026-08-13 10-Q10-Q
2026-05-22 424B3424B3
2026-05-22 424B3424B3
2026-05-22 424B3424B3
2026-05-14 424B3424B3
2026-05-14 424B3424B3
2026-05-14 10-Q10-Q
2026-05-13 EFFECT
2026-05-11 POS AMPOS AM
2026-04-30 424B3424B3
2026-04-28 EFFECT

Common questions about KBLB

Does KBLB file reports with the SEC?

Yes. Kraig Biocraft Laboratories files with the SEC under company number 0001413119. The most recent filing we hold is a 10-Q dated 2026-11-16.

Source record

How many KBLB shares are outstanding?

1,099,791,733 shares as of 2026-03-30, as reported to the SEC.

Source record

Has KBLB filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is Kraig Biocraft Laboratories making money?

The company lost $3.6 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record